High Costs Keep Many Cancer Patients From Needed Drugs

THURSDAY, Dec. 21, 2017 — Cancer drugs have become so pricey that U.S. patients often can’t afford them, a new study finds.
The findings suggest that high out-of-pocket costs may be a barrier to potentially life-saving or life-prolonging…
Source: Topamax